Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

Apr 20, 2004

29777_dirs_2004-04-20_8537691c-4fc9-4c93-ac87-42768fb4fa02.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-04-16

Reporting Person: WASCOE THOMAS M (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-04-16 Common shares without par value M 19127 $34.70 Acquired 79676 Direct
2004-04-16 Common shares without par value F 16685 $43.97 Disposed 62991 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-04-16 Option (right to buy) $34.70 M 12741 Disposed 2010-02-10 common shares (12741) Direct
2004-04-16 Option (right to buy) $34.70 M 6386 Disposed 2010-02-10 common shares (6386) Direct
2004-04-16 Option (right to buy) $43.97 A 16685 Acquired 2010-02-10 common shares (16685) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 8990 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 16, 2004.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.